» Articles » PMID: 15113878

The BRRF1 Early Gene of Epstein-Barr Virus Encodes a Transcription Factor That Enhances Induction of Lytic Infection by BRLF1

Overview
Journal J Virol
Date 2004 Apr 29
PMID 15113878
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

The switch from the latent to the lytic form of Epstein-Barr virus (EBV) infection is mediated by expression of the viral immediate-early (IE) proteins, BZLF1 (Z) and BRLF1 (R). An EBV early protein, BRRF1 (Na), is encoded by the opposite strand of the BRLF1 intron, but the function of this nuclear protein in the viral life cycle is unknown. Here we demonstrate that Na enhances the R-mediated induction of lytic EBV infection in 293 cells latently infected with a recombinant EBV (R-KO) defective for the expression of both R and Na. Na also enhances R-induced lytic infections in a gastric carcinoma line (AGS) carrying the R-KO virus, although it has no effect in a Burkitt lymphoma line (BL-30) stably infected with the same mutant virus. We show that Na is a transcription factor that increases the ability of R to activate Z expression from the R-KO viral genome in 293 cells and that Na by itself activates the Z promoter (Zp) in EBV-negative cells. Na activation of Zp requires a CRE motif (ZII), and a consensus CRE motif is sufficient to transfer Na responsiveness to the heterologous E1b promoter. Furthermore, we show that Na enhances the transactivator function of a Gal4-c-Jun fusion protein but does not increase the transactivator function of other transcription factors (including ATF-1, ATF-2, and CREB) known to bind CRE motifs. Na expression in cells results in increased levels of a hyperphosphorylated form of c-Jun, suggesting a mechanism by which Na activates c-Jun. Our results indicate that Na is a transcription factor that activates the EBV Zp IE promoter through its effects on c-Jun and suggest that Na cooperates with BRLF1 to induce the lytic form of EBV infection in certain cell types.

Citing Articles

Epstein-Barr Virus BRRF1 Induces Butyrophilin 2A1 in Nasopharyngeal Carcinoma NPC43 Cells via the IL-22/JAK3-STAT3 Pathway.

Liu Y, Lui K, Ye Z, Chen L, Cheung A Int J Mol Sci. 2025; 25(24.

PMID: 39769218 PMC: 11677325. DOI: 10.3390/ijms252413452.


Rta is the principal activator of Epstein-Barr virus epithelial lytic transcription.

Ali A, Ohashi M, Casco A, Djavadian R, Eichelberg M, Kenney S PLoS Pathog. 2022; 18(9):e1010886.

PMID: 36174106 PMC: 9553042. DOI: 10.1371/journal.ppat.1010886.


Epstein-Barr Virus and the Origin of Myalgic Encephalomyelitis or Chronic Fatigue Syndrome.

Ruiz-Pablos M, Paiva B, Montero-Mateo R, Garcia N, Zabaleta A Front Immunol. 2021; 12:656797.

PMID: 34867935 PMC: 8634673. DOI: 10.3389/fimmu.2021.656797.


Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Human Herpesviruses Are Back!.

Ariza M Biomolecules. 2021; 11(2).

PMID: 33572802 PMC: 7912523. DOI: 10.3390/biom11020185.


Reactivation of Epstein-Barr Virus by HIF-1α Requires p53.

Kraus R, Cordes B, Sathiamoorthi S, Patel P, Yuan X, Iempridee T J Virol. 2020; 94(18).

PMID: 32641480 PMC: 7459560. DOI: 10.1128/JVI.00722-20.


References
1.
Liu S, Borras A, Liu P, Suske G, Speck S . Binding of the ubiquitous cellular transcription factors Sp1 and Sp3 to the ZI domains in the Epstein-Barr virus lytic switch BZLF1 gene promoter. Virology. 1997; 228(1):11-8. DOI: 10.1006/viro.1996.8371. View

2.
Karimi L, Crawford D, Speck S, Nicholson L . Identification of an epithelial cell differentiation responsive region within the BZLF1 promoter of the Epstein-Barr virus. J Gen Virol. 1995; 76 ( Pt 4):759-65. DOI: 10.1099/0022-1317-76-4-759. View

3.
Chang Y, Dong D, Hayward G, Hayward S . The Epstein-Barr virus Zta transactivator: a member of the bZIP family with unique DNA-binding specificity and a dimerization domain that lacks the characteristic heptad leucine zipper motif. J Virol. 1990; 64(7):3358-69. PMC: 249580. DOI: 10.1128/JVI.64.7.3358-3369.1990. View

4.
Gruffat H, Manet E, Rigolet A, Sergeant A . The enhancer factor R of Epstein-Barr virus (EBV) is a sequence-specific DNA binding protein. Nucleic Acids Res. 1990; 18(23):6835-43. PMC: 332739. DOI: 10.1093/nar/18.23.6835. View

5.
Sinclair A, Brimmell M, Shanahan F, Farrell P . Pathways of activation of the Epstein-Barr virus productive cycle. J Virol. 1991; 65(5):2237-44. PMC: 240572. DOI: 10.1128/JVI.65.5.2237-2244.1991. View